GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (FRA:9O6) » Definitions » Minority Interest

Molekule Group (FRA:9O6) Minority Interest : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Molekule Group's minority interest for the quarter that ended in Jun. 2023 was €0.00 Mil.


Molekule Group Minority Interest Historical Data

The historical data trend for Molekule Group's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Minority Interest Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Minority Interest
- - - -

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Molekule Group Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Molekule Group (FRA:9O6) Business Description

Traded in Other Exchanges
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Molekule Group (FRA:9O6) Headlines

No Headlines